MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms.
Saved in:
| Title: | MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms. |
|---|---|
| Authors: | Dumas PY; CHU de Bordeaux, Hématologie Clinique et Thérapie Cellulaire, F-33000, Bordeaux, France.; INSERM U1035, Université de Bordeaux, Bordeaux, France., Mansier O; INSERM U1218, Université de Bordeaux, Bordeaux, France.; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France., Prouzet-Mauleon V; INSERM U1218, Université de Bordeaux, Bordeaux, France., Koya J; Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, bunkyo-ku, Tokyo, 113-8655, Japan., Villacreces A; INSERM U1035, Université de Bordeaux, Bordeaux, France., Brunet de la Grange P; Etablissement Français du Sang - Aquitaine Limousin, Laboratoire R&D d'Ingénierie Cellulaire, Université de Bordeaux, Bordeaux, France., Luque Paz D; CHRU d'Angers, Laboratoire d'Hématologie, Angers, France., Bidet A; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France., Pasquet JM; INSERM U1035, Université de Bordeaux, Bordeaux, France., Praloran V; INSERM U1035, Université de Bordeaux, Bordeaux, France.; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France., Salin F; INRA, Plateforme Génome Transcriptome de Bordeaux, BIOGECO, UMR 1202, F-33610, Cestas, France., Kurokawa M; Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, bunkyo-ku, Tokyo, 113-8655, Japan., Mahon FX; INSERM U1218, Université de Bordeaux, Bordeaux, France.; Institut Bergonié, Bordeaux, France., Cardinaud B; INSERM U1218, Université de Bordeaux, Bordeaux, France.; Bordeaux Institut National Polytechnique, F-33000, Bordeaux, France., Lippert E; INSERM U1035, Université de Bordeaux, Bordeaux, France. eric.lippert@chu-brest.fr.; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France. eric.lippert@chu-brest.fr.; CHRU de Brest, Service d'Hématologie Biologique et INSERM U1078, Université de Bretagne Occidentale, Brest, France. eric.lippert@chu-brest.fr. |
| Source: | BMC cancer [BMC Cancer] 2018 Nov 12; Vol. 18 (1), pp. 1098. Date of Electronic Publication: 2018 Nov 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30419846 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dumas+PY%22">Dumas PY</searchLink>; CHU de Bordeaux, Hématologie Clinique et Thérapie Cellulaire, F-33000, Bordeaux, France.; INSERM U1035, Université de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Mansier+O%22">Mansier O</searchLink>; INSERM U1218, Université de Bordeaux, Bordeaux, France.; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Prouzet-Mauleon+V%22">Prouzet-Mauleon V</searchLink>; INSERM U1218, Université de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Koya+J%22">Koya J</searchLink>; Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, bunkyo-ku, Tokyo, 113-8655, Japan.<br /><searchLink fieldCode="AU" term="%22Villacreces+A%22">Villacreces A</searchLink>; INSERM U1035, Université de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Brunet+de+la+Grange+P%22">Brunet de la Grange P</searchLink>; Etablissement Français du Sang - Aquitaine Limousin, Laboratoire R&D d'Ingénierie Cellulaire, Université de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Luque+Paz+D%22">Luque Paz D</searchLink>; CHRU d'Angers, Laboratoire d'Hématologie, Angers, France.<br /><searchLink fieldCode="AU" term="%22Bidet+A%22">Bidet A</searchLink>; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Pasquet+JM%22">Pasquet JM</searchLink>; INSERM U1035, Université de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Praloran+V%22">Praloran V</searchLink>; INSERM U1035, Université de Bordeaux, Bordeaux, France.; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Salin+F%22">Salin F</searchLink>; INRA, Plateforme Génome Transcriptome de Bordeaux, BIOGECO, UMR 1202, F-33610, Cestas, France.<br /><searchLink fieldCode="AU" term="%22Kurokawa+M%22">Kurokawa M</searchLink>; Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo, 7-3-1, Hongo, bunkyo-ku, Tokyo, 113-8655, Japan.<br /><searchLink fieldCode="AU" term="%22Mahon+FX%22">Mahon FX</searchLink>; INSERM U1218, Université de Bordeaux, Bordeaux, France.; Institut Bergonié, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Cardinaud+B%22">Cardinaud B</searchLink>; INSERM U1218, Université de Bordeaux, Bordeaux, France.; Bordeaux Institut National Polytechnique, F-33000, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Lippert+E%22">Lippert E</searchLink>; INSERM U1035, Université de Bordeaux, Bordeaux, France. eric.lippert@chu-brest.fr.; CHU de Bordeaux, Laboratoire d'Hématologie, F-33000, Bordeaux, France. eric.lippert@chu-brest.fr.; CHRU de Brest, Service d'Hématologie Biologique et INSERM U1078, Université de Bretagne Occidentale, Brest, France. eric.lippert@chu-brest.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2018 Nov 12; Vol. 18 (1), pp. 1098. <i>Date of Electronic Publication: </i>2018 Nov 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30419846 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-018-4993-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1098 Titles: – TitleFull: MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dumas PY – PersonEntity: Name: NameFull: Mansier O – PersonEntity: Name: NameFull: Prouzet-Mauleon V – PersonEntity: Name: NameFull: Koya J – PersonEntity: Name: NameFull: Villacreces A – PersonEntity: Name: NameFull: Brunet de la Grange P – PersonEntity: Name: NameFull: Luque Paz D – PersonEntity: Name: NameFull: Bidet A – PersonEntity: Name: NameFull: Pasquet JM – PersonEntity: Name: NameFull: Praloran V – PersonEntity: Name: NameFull: Salin F – PersonEntity: Name: NameFull: Kurokawa M – PersonEntity: Name: NameFull: Mahon FX – PersonEntity: Name: NameFull: Cardinaud B – PersonEntity: Name: NameFull: Lippert E IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 11 Text: 2018 Nov 12 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 18 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |
